Applied UV (AUVI)
OTHER OTC:AUVI
Top Page
No summary available
Positive Factors
Revenue Growth
Strong revenue growth indicates increasing demand for Applied UV's disinfection solutions, suggesting successful market penetration and potential for future expansion.
Negative Factors
Profitability Challenges
Persistent profitability issues despite revenue growth highlight cost management problems, which could hinder long-term financial health.
Read all positive and negative factors
Positive Factors
Negative Factors
Revenue Growth
Strong revenue growth indicates increasing demand for Applied UV's disinfection solutions, suggesting successful market penetration and potential for future expansion.
Read all positive factors
Applied UV (AUVI) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.87K
Dividend YieldN/A
Average Volume (3M)1.27K
Price to Earnings (P/E)―
Beta (1Y)10.34
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees131
SectorConsumer Cyclical
Sector Strength84
IndustryFurnishings, Fixtures & Appliances
Share Statistics
EPS (TTM)N/A
Shares Outstanding4,674,495
10 Day Avg. Volume1,275
30 Day Avg. Volume1,275
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.04
Price to Sales (P/S)0.02
P/FCF Ratio-0.10
Enterprise Value/Market Cap4.52K
Enterprise Value/Revenue0.21
Enterprise Value/Gross Profit1.08
Enterprise Value/Ebitda-1.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Applied UV Business Overview & Revenue Model
Company Description
Applied UV, Inc., through its subsidiaries, develops, acquires, and commercializes technology that addresses air purification and infection control in the healthcare, hospitality, commercial, municipal, and residential markets in the United States...
How the Company Makes Money
Applied UV generates revenue primarily through the sale of its UV disinfection systems and related services. The company's key revenue streams include direct sales to healthcare facilities, hotels, food processing plants, and other commercial enti...
Applied UV Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | Dec 2023 | Mar 2023 | Mar 2022 | Dec 2020 | Dec 2019 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 40.72M | 20.14M | 11.67M | 5.73M | 9.33M |
| Gross Profit | 7.83M | 4.04M | 4.10M | 1.01M | 3.32M |
| EBITDA | -7.42M | -12.80M | -5.71M | -3.30M | 2.70M |
| Net Income | -13.20M | -22.05M | -7.39M | -3.37M | 2.80M |
Balance Sheet | |||||
| Total Assets | 58.39M | 32.73M | 38.53M | 13.12M | 4.77M |
| Cash, Cash Equivalents and Short-Term Investments | 1.13M | 2.73M | 7.92M | 11.76M | 1.03M |
| Total Debt | 8.21M | 7.77M | 1.90M | 950.64K | 793.61K |
| Total Liabilities | 33.50M | 15.49M | 5.86M | 3.36M | 3.38M |
| Stockholders Equity | 24.88M | 17.23M | 32.67M | 9.75M | 1.38M |
Cash Flow | |||||
| Free Cash Flow | -8.78M | -8.76M | -7.03M | -875.86K | 757.26K |
| Operating Cash Flow | -8.22M | -8.74M | -7.00M | -657.23K | 770.26K |
| Investing Cash Flow | -4.84M | -176.28K | -14.59M | -218.63K | -13.00K |
| Financing Cash Flow | 11.46M | 2.88M | 18.60M | 11.60M | -521.09K |
Applied UV Risk Analysis
Applied UV disclosed 85 risk factors in its most recent earnings report. Applied UV reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 3 New Risks
1.
Anti-takeover provisions in our charter documents and Nevada law could discourage delay or prevent a change of control of our Company and may affect the trading price of our common stock. Q4, 2023
2.
If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, our stock price and trading volume could decline. Q4, 2023
3.
We stopped paying dividends on our Series A Preferred Stock effective June 23, 2023 and if we continue to stop paying dividends and fail to pay all dividends in arrears prior to or on June 23, 2024, the holders of the Series A Preferred Stock and any preferred stock on parity with the Series A Preferred Stock have the ability to elect a majority of the Board and as a result, there may be significant implications for corporate governance and strategic decision making. Q4, 2023
Applied UV Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
| ― | $1.87K | ― | ― | ― | ― | ― | |
56 Neutral | $170.36M | -3.18 | -13.50% | 4.51% | -1.76% | -67.05% | |
45 Neutral | $7.30M | -0.29 | -47.45% | ― | -26.81% | 40.22% | |
44 Neutral | $7.05M | -1.78 | -18.10% | ― | 6.66% | -1404.42% | |
| ― | $3.57M | -3.59 | -179.41% | ― | -16.56% | -39.85% |
* Consumer Cyclical Sector Average
AUVI
Applied UV
0.01
0.00
0.00%
LCUT
Lifetime Brands
7.52
3.71
97.48%
EFOI
Energy Focus
1.97
0.33
19.94%
ATER
Aterian
0.67
-1.11
-62.13%
FGI
FGI Industries Ltd
3.67
1.20
48.58%
NCL
Northann Corp.
0.16
-1.56
-90.93%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―